Full Text
Gemifloxacin as first line treatment for community acquired pneumonia in mexico- A cost—effectiveness study

Abstract

Authors

R.M. Galindo-Suárez G. Salinas-Escudero E. Muciño-Ortega

Back to Volume 16, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×